Cancer Communications
indexed by SCI

About the cover
About the cover

Jun. 2017; Volume 36 Issue 6

June 1996, Matthew Scott discovers a gene responsible for basal cell carcinoma, the most common human cancer.
June 2006, FDA approves Gardasil, a vaccine that protects against the virus that causes most cervical cancers.

Research Highlight
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Dong Wang, Ruikai Du and Suling Liu
[ Abstract  784]  [ PDF Full-text  914]   [ HTML Full-text  512]    Epub: 2017-4-1  doi: 10.1186/s40880-017-0204-9
The 150 most important questions in cancer research and clinical oncology series: questions 31-39
Editorial Office of the Chinese Journal of Cancer
[ Abstract  874]  [ PDF Full-text  1065]   [ HTML Full-text  267]    Epub: 2017-6-2  doi: 10.1186/s40880-017-0215-6
Immunological effect of local ablation combined with immunotherapy on solid malignancies
Yusuke Takahashi, Noriyuki Matsutani, Takashi Nakayama, Hitoshi Dejima, Hirofumi Uehara and Masafumi Kawamura
[ Abstract  831]  [ PDF Full-text  1232]   [ HTML Full-text  355]    Epub: 2017-6-7  doi: 10.1186/s40880-017-0216-5
Original Article
CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China
Yanfen Feng, Huilan Rao, Yiyan Lei, Yuhua Huang, Fang Wang, Yu Zhang, Shaoyan Xi, Qiuliang Wu and Jianyong Shao
[ Abstract  877]  [ PDF Full-text  1043]   [ HTML Full-text  283]    Epub: 2017-5-10  doi: 10.1186/s40880-017-0212-9
Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients
Jun-Yan Liu, Chen-Yue Qian, Yuan-Feng Gao, Juan Chen, Hong-Hao Zhou and Ji-Ye Yin
[ Abstract  701]  [ PDF Full-text  1178]   [ HTML Full-text  670]    Epub: 2017-1-17  doi: 10.1186/s40880-016-0175-2
Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial
Qiu-Wen Tan, Ting Luo, Hong Zheng, Ting-Lun Tian, Ping He, Jie Chen, He-Lin Zeng and Qing Lv
[ Abstract  736]  [ PDF Full-text  1183]   [ HTML Full-text  651]    Epub: 2017-3-8  doi: 10.1186/s40880-017-0196-5
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
Kadri Altundag
[ Abstract  766]  [ PDF Full-text  1069]   [ HTML Full-text  510]    Epub: 2017-5-16  doi: 10.1186/s40880-017-0208-5

CC Wechat 微信公众号


Editorial Manager

CC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China